ArticleTranslational breast cancer research : a journal focusing on translational research in breast cancer2026
Can neoadjuvant chemotherapy be replaced with immune checkpoint blockade combined with dual anti-HER2 antibodies for HER2-enriched breast cancer?
Harry D BearPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.